Skip to main content
SLSBio(Specialty Lab Solution Bio) Co., Ltd logo

SLSBio(Specialty Lab Solution Bio) Co., Ltd — Investor Relations & Filings

Ticker · 246250 ISIN · KR7246250005 KO Professional, scientific and technical activities
Open in API
Filings indexed 261 across all filing types
Latest filing 2024-12-18 Major Shareholding Noti…
Country KR South Korea
Listing KO 246250

About SLSBio(Specialty Lab Solution Bio) Co., Ltd

http://www.slabs.co.kr/

SLSBio (Specialty Lab Solution Bio) Co., Ltd. is a company specializing in laboratory solutions and support services for the pharmaceutical and biotechnology sectors. Its primary offerings include pharmaceutical quality control testing, clinical trial sample analysis, bioequivalence studies, drug stability testing, and new drug development support. In addition to its service portfolio, the company develops and manufactures diagnostic technologies, reagents, and other biological agents, supporting various stages of the drug development and commercialization lifecycle.

Recent filings

Filing Released Lang Actions
주식등의대량보유상황보고서(일반)
Major Shareholding Notification Classification · 100% confidence The document is a 'Report on the Status of Large Shareholdings' (주식등의 대량보유상황보고서), which is a standard regulatory filing in South Korea (often referred to as the 5% rule filing). It details the share ownership, changes in holdings, and the purpose of holding (management influence) by major shareholders and their special relations. This falls under the category of Major Shareholding Notification.
2024-12-18 Korean
주주명부폐쇄기간또는기준일설정
Notice of Dividend Amount Classification · 95% confidence The document is a short regulatory announcement regarding the setting of a record date for the purpose of determining shareholders eligible to vote at the upcoming 18th Annual General Meeting. It does not contain the full proxy materials or the meeting presentation itself, but rather serves as a formal notice of a corporate action (setting a record date). Given it is a standard regulatory notification regarding shareholder rights and meeting preparation, it falls under the general regulatory filing category.
2024-12-09 Korean
분기보고서 (2024.09)
Interim / Quarterly Report Classification · 100% confidence The document is a 'Quarterly Report' (분기보고서) for the company 'SLS Bio' (주식회사 에스엘에스바이오) covering the period from January 1, 2024, to September 30, 2024. It contains detailed financial information, business operations, and management discussions, which aligns with the definition of an Interim/Quarterly Report (IR). 9M 2024
2024-11-13 Korean
[기재정정]주요사항보고서(유형자산양수결정)
Regulatory Filings Classification · 100% confidence The document is a formal regulatory filing submitted to the Korea Exchange (KRX) regarding a 'Decision to Acquire Tangible Assets' (유형자산 양수 결정). It includes a correction report (정정신고) detailing changes to the initial disclosure. This type of filing, which concerns significant corporate transactions and asset acquisitions, falls under the category of general regulatory announcements and filings that do not fit into more specific categories like earnings or dividends.
2024-10-04 Korean
주요사항보고서(자기주식취득신탁계약체결결정)
Transaction in Own Shares Classification · 100% confidence The document is a 'Major Matter Report' (주요사항보고서) filed with the Korean Financial Supervisory Service/Korea Exchange. It specifically details the company's decision to enter into a trust agreement for the acquisition of its own shares (자기주식취득 신탁계약 체결 결정). According to the provided filing definitions, reports regarding a company buying back its own shares are classified as 'Transaction in Own Shares' (POS).
2024-10-02 Korean
[첨부추가]주요사항보고서(유형자산양수결정)
M&A Activity Classification · 100% confidence The document is a 'Major Matter Report' (주요사항보고서) filed with the Korea Exchange (KRX) regarding the acquisition of tangible assets (real estate/land and buildings) by SLS Bio. This type of regulatory filing, which discloses significant corporate transactions or material events, falls under the 'Regulatory Filings' category as it does not fit into specific categories like M&A (which usually refers to corporate mergers/acquisitions) or capital changes.
2024-10-02 Korean

Browse filings by year

9 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.